NovoCure Ltd. (NVCR)
13.70
-1.29
(-8.61%)
USD |
NASDAQ |
Feb 26, 15:43
NovoCure Research and Development Expense (Quarterly) : 54.03M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| LivaNova Plc | 51.30M |
| AtriCure, Inc. | 22.74M |
| Abbott Laboratories | 721.00M |
| Accuray, Inc. | 10.65M |
| Plus Therapeutics, Inc. | 2.436M |